Sunday, December 21, 2025 | 12:01 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Fosun plans to sell of India's $3.8 billion drug maker Gland Pharma

Fosun Pharma, a listed arm of Chinese conglomerate Fosun International Ltd., has been working with an adviser as it informally gauges interest in its controlling stake in Gland, the people said

Fosun Pharma, Chinese drug firm, Fosun
premium

A company logo is pictured at the headquarters of Shanghai Fosun Pharma Group in Shanghai, China. (Photo: Reuters)

Dong Cao, Manuel Baigorri | Bloomberg
Billionaire Guo Guangchang’s Shanghai Fosun Pharmaceutical Group Co. is considering a sale of Indian drugmaker Gland Pharma Ltd. after receiving interest from potential buyers, people familiar with the matter said. 
 
Fosun Pharma, a listed arm of Chinese conglomerate Fosun International Ltd., has been working with an adviser as it informally gauges interest in its controlling stake in Gland, the people said. Companies in the industry and buyout firms are in the early stages of studying the business, the people said, asking not to be identified because the matter is private. 

Shares of Gland climbed 7.6 per cent in Mumbai on